Clinical trials
Phase 3 Alzheimer Disease trials in Austria
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
| Completed | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Biogen | 2 |
| JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2 |
| Eisai Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| Novo Nordisk A/S | 1 |
| Pfizer | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 12 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Lymphoma, Follicular | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.